Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: 1. subjects with chronic liver disease (cld) at the humanity and health medical group and eligible for the hk government vaccination programme; 2. able to understand and sign informed consent.; 3. underlying cld- defined as patients with chronic hepatitis b or c infections, liver cirrhosis, metabolic associated liver disease, hepatocellular carcinoma, alcoholic liver disease, autoimmune hepatitis, hemochrombtosis.

inclusion criteria: 1. subjects with chronic liver disease (cld) at the humanity and health medical group and eligible for the hk government vaccination programme; 2. able to understand and sign informed consent.; 3. underlying cld- defined as patients with chronic hepatitis b or c infections, liver cirrhosis, metabolic associated liver disease, hepatocellular carcinoma, alcoholic liver disease, autoimmune hepatitis, hemochrombtosis.

Nov. 16, 2021, 6:30 p.m. usa

inclusion criteria: subjects with chronic liver disease (cld) at the humanity and health medical group and eligible for the hk government vaccination programme; able to understand and sign informed consent.; underlying cld- defined as patients with chronic hepatitis b or c infections, liver cirrhosis, metabolic associated liver disease, hepatocellular carcinoma, alcoholic liver disease, autoimmune hepatitis, hemochrombtosis.

inclusion criteria: subjects with chronic liver disease (cld) at the humanity and health medical group and eligible for the hk government vaccination programme; able to understand and sign informed consent.; underlying cld- defined as patients with chronic hepatitis b or c infections, liver cirrhosis, metabolic associated liver disease, hepatocellular carcinoma, alcoholic liver disease, autoimmune hepatitis, hemochrombtosis.

March 2, 2021, 12:31 a.m. usa

inclusion criteria: 1. subjects with chronic liver disease (cld) at the humanity and health medical group and eligible for the hk government vaccination programme; 2. able to understand and sign informed consent.; 3. underlying cld- defined as patients with chronic hepatitis b or c infections, liver cirrhosis, metabolic associated liver disease, hepatocellular carcinoma, alcoholic liver disease, autoimmune hepatitis, hemochrombtosis.

inclusion criteria: 1. subjects with chronic liver disease (cld) at the humanity and health medical group and eligible for the hk government vaccination programme; 2. able to understand and sign informed consent.; 3. underlying cld- defined as patients with chronic hepatitis b or c infections, liver cirrhosis, metabolic associated liver disease, hepatocellular carcinoma, alcoholic liver disease, autoimmune hepatitis, hemochrombtosis.